RXPC ~ In my humble opinion I don't understand the holdup with 18 Million? I would almost categorize RXPC as a Biotech. Biotech's command little respect and are usually the moving target of short sellers. Short sellers always expect biotech's to run out of money before they get FDA approval. 18 million in my opinion is nothing considering RXPC already has an FDA approved test kit. You might already know but, if you do some digging you will find their test kit is anything but lackluster. I think some big things are in the works. In my opinion this will spike hard.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.